BackBiotech Acquisition Overview

Biotech Acquisition Accounts Payable

Track Biotech Acquisition's accounts payable ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00
100.00% YoYΔ $-357683.00 vs prior year quarter

Peer average

Loading

Biotech Acquisition Accounts Payable History

Loading

Biotech Acquisition vs. peers: Accounts Payable Comparison

Loading

Biotech Acquisition Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Biotech Acquisition (BIOT) FAQ

Biotech Acquisition (BIOT) currently reports a accounts payable of $0 as of September 2022. That compares with $360K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Biotech Acquisition's accounts payable history and peer comparisons.

Biotech Acquisition's accounts payable decreased from $360K to $0 — a 100.0% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biotech Acquisition reported $0 in accounts payable as of September 2022. That compares with $360K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biotech Acquisition, and consider following BIOT for alerts when major investors trade the stock.